導管，經皮，心臟消融，用於治療心房顫動
PMA 核准號：P110016 · 2026-08-07
廣告
器材摘要
catheter, percutaneous, cardiac ablation, for treatment of atrial flutter is the device name listed in this FDA 510(k) record. The listed applicant is ABBOTT MEDICAL. It received FDA 510(k) clearance on 2026-08-07. The device is classified under product code OAD. It was reviewed by the CV advisory panel.
常見問題
What is the catheter, percutaneous, cardiac ablation, for treatment of atrial flutter?
catheter, percutaneous, cardiac ablation, for treatment of atrial flutter is a medical device that received FDA 510(k) clearance on 2026-08-07. The listed applicant is ABBOTT MEDICAL.
When did catheter, percutaneous, cardiac ablation, for treatment of atrial flutter receive FDA 510(k) clearance?
The clearance date for catheter, percutaneous, cardiac ablation, for treatment of atrial flutter can be found in the official FDA records.
誰是為治療心房顫動而列出的導管、經皮、心內消融的申請人？
The FDA 510(k) record lists ABBOTT MEDICAL as the applicant. This does not by itself establish the device manufacturer.
FDA產品代碼為何？針對治療心房顫動的經皮心臟消融術用的導管？
FDA產品代碼對於治療心房顫動的經皮心臟消融導管為 OAD。
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告